Optimal treatment of erectile dysfunction (ED) following radical prostatectomy remains a subject of much controversy and is a significant concern for prostate cancer patients requiring surgical intervention. Neural stimulation involving nitric oxide synthase (NOS) is a crucial aspect of the normal erection process. In this study NOS isoform interaction was evaluated to improve our understanding of molecular changes pertaining to erection post radical prostatectomy. Bilateral cavernous nerve (CN) resected and control adult male Sprague-Dawley rats were killed 7, 14 and 21 days after injury. RT-PCR, in situ hybridization, Western blot and immunohistochemical analysis were used to evaluate changes in NOS isoform expression and distribution. NOS-I protein was dramatically decreased after CN injury while NOS-III and NOS-II remained unchanged. A profound decrease in smooth muscle and endothelium was observed in the corpora. To our knowledge this is the first report of differential altered NOS isoform protein abundance under conditions which mimic radical prostatectomy. These results show the importance of maintaining at least partial innervation of the penis after surgical intervention and that endothelial and smooth muscle changes resulting from loss of innervation may account for the ED observed in prostatectomy patients.
Introduction
Optimal treatment of erectile dysfunction (ED) following radical prostatectomy remains a subject of much controversy and is a significant concern for prostate cancer patients requiring surgical intervention. Patient outcomes have improved substantially with the advent of more sensitive early detection techniques. This has resulted in a greater concern for quality of life post surgical intervention. ED is a condition that frequently accompanies radical prostatectomy and radiation treatment for prostate cancer. At least a third of patients treated by radiotherapy and 30-70% of patients treated by radical prostatectomy experience ED. 1 Current treatment options available after radical prostatectomy, including self-injection or intra-urethral administration of alprostadil, vacuum erection devices and sildenafil therapy, are only partially effective. 1 Although the cause of post radical ED has been attributed to nerve damage, this view has been questioned recently with the potential for a vascular component. The importance of neural innervation to post radical erectile function has been partially evaluated in a clinical setting where nerve-sparing prostatectomy was possible. The inability to spare cavernous nerves at the time of radical prostatectomy leads to ED in many men. 2, 3 Approximately half the patients recovered erectile function within 3 y and as many as 80% after 5 y. This improvement in erectile function was suggested to accompany neural regeneration. [4] [5] [6] [7] [8] [9] The recovery of sexual intercourse rates were substantially lower, 36 and 57% respectively. 10 Thus neural integrity appears to play an essential role in erectile function.
Neural stimulation involving nitric oxide synthase (NOS) is a crucial aspect of the normal erection process. 11 Erection requires both parasympathetic, neuronally mediated relaxation of blood vessels and relaxation of the trabecular meshwork of smooth muscle that comprises the corpora cavernosa. 12 The pelvic ganglia regulates blood flow into the penis. When stimulated the pelvic ganglia induces erection 13 through stimulation of postganglionic neurons, such as the cavernous nerve. They innervate the penis and produce nitric oxide. Nitric oxide is a ubiquitous neurotransmitter that is synthesized from L-arginine in the non-adrenergic non-cholinergic nerve terminals 14 and which governs smooth muscle relaxation. NOS is the primary regulator of nitric oxide. Several different isoforms of NOS have been identified that are tissue and organ specific. NOS-I has been localized primarily to neuronal cells 15 but is also expressed in smooth muscle of the corpora and in the epithelium of the urethra; 16 it is Ca 2þ dependent 17 and can be subdivided into three distinct transcripts, NOS-Ia, NOS-Ib and NOS-Ic 18 that have distinct 5 0 untranslated first exons that arise from alternative splicing to a common second exon NOS-Ia and NOS-Ib have been identified in the penis while NOS-Ic has not. 16 NOS-II is often expressed in cells following immunological stimulation (expressed in cytokine induced macrophages) as a host defense mechanism, is Ca 2þ independent and plays a role in the inflammatory process. [19] [20] [21] [22] NOS-III is abundant in smooth muscle, endothelium and epithelium, 8, 16 is regulated acutely by Ca 2þ , 17 and chronically by sheer stress. 23 The penis normally demonstrates high levels of NOS, however, in the presence of conditions that contribute to ED, such as diabetes, aging, chronic smoking and hypogonadism, enzyme activity is reduced. 24 How the NOS isoforms cooperatively achieve erection is unclear and the potential for isoform compensation due to genetic deficiency or surgical intervention is controversial but has substantial potential as an avenue for ED treatment.
In approximately 50% of prostatectomy patients ED treatment with oral therapy was inadequate to restore function. 1, 25 The bilateral cavernous nerve (CN) model that we have studied mimics the circumstances of post radical prostatectomy patients in which the CN has been damaged or severed and erectile function was lost. This model is ideally suited to gather insight into how NOS isoform expression changes with nerve damage and to evaluate the potential for NOS therapy to treat ED. Unilateral CN resection is not an adequate model for radical prostatectomy patients since it more closely depicts the process of neural regeneration. In this work we have examined the relationship between NOS-I (-Ia and -Ib), -II and -III isoforms under conditions which mimic non-nerve sparing radical prostatectomy, post CN resection. NOS-I protein was dramatically decreased after bilateral CN resection. NOS-III and NOS-II isoforms remained constant post CN and compensation by these isoforms to maintain erectile function post surgery was not observed. A dramatic decrease in both smooth muscle and endothelium of the corpora cavernosa was apparent that can account for the ED observed post radical prostatectomy. These results show that ED associated with non-nerve sparing radical prostatectomy may be attributed specifically to changes in NOS-I protein and that in the absence of a stimulatory pathway from the central nervous system that other NOS isoforms do not compensate for the loss of NOS-I. These experiments suggest that NOS therapy has substantial potential as a therapeutic agent for ED if at least partial nerve sparing is possible.
Materials and methods

Animals
Sprague-Dawley rats were obtained from an established breeding colony (Charles Rivers). Animals were cared for in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals. Postnatal day 120 (P120) Sprague-Dawley rats were randomized into two groups: bilateral CN resection (n ¼ 36) and sham abdominal exploration (control, n ¼ 36). Nerve resection involved removing a 5 mm section of each cavernous nerve using a KAPS Industrial microscope under direct vision through a midline abdominal incision. The prostatic capsule was manipulated in sham (control) animals without resecting the cavernous nerve. Stress related fluctuations of serum testosterone were minimized at the time of abdominal exploration through bilateral epididymo-orchiectomy and subcutaneous placement of a 2 cm piece of medical grade silastic tubing (Dow Corning Corp., Midland, MI, USA) filled with crystalline testosterone. This method first described by Wang et al 26 ensures reliable, uniform serum testosterone levels for both the control and intervention groups up to 28 days after placement. We verified this with our own serum testosterone assay for all animals, which revealed uniform, physiological levels at all three time periods. Eliminating variation in testosterone levels between animals is necessary since decreased testosterone can significantly lower NOS-I and -III. 27 Penises were harvested from euthanized males by sharp dissection 7, 14 and 21 days post initial CN resection and were either snap frozen in liquid nitrogen or fixed in 4% paraformaldehyde.
RT-PCR (reverse transcriptase polymerase chain reaction)
We have characterized gene expression of several NOS isoforms post CN injury using a non-competitive method of RT-PCR that utilizes either glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or malate dehydrogenase (MDH) as an endogenous internal standard. 16, [28] [29] [30] [31] [32] Total RNA was isolated from Sprague-Dawley penises using the TRIzol (Gibco BRL, Grand Island, NY, USA) method, the RNA was DNAse treated with RQ1 DNAse (Roche, Indianapolis, IN, USA) to eliminate any genomic DNA contamination and was suspended in water.
The presence of any remaining DNA contamination was assessed by RT-PCR with the reverse transcriptase enzyme omitted. RT-PCR was performed on 150 ng total RNA (per tube) using the Gene Amp RNA PCR Core kit (Perkin-Elmer, Branchburg, NJ, USA). The primers were synthesized at the Northwestern University Biotechnology Facility. Previous work from our laboratory have demonstrated the presence of specific splice variants of NOS-I, NOSIa, NOS-Ib, in normal penises. 16 In this study RT-PCR was performed to assess NOS-Ia, NOS-Ib, and NOS-III expression in normal and CN cut penises. Products were restriction digested to confirm they represented the sequence of interest. Product sizes and primer sequences are outlined in Table 1 .
Quantitative reverse transcriptase polymerase chain reaction (RT-PCR)
Semi-quantitative RT-PCR was performed by determining the ratio between the products for NOS-III=GAPDH, NOS-Ib=malate dehydrogenase (MDH) and NOS-Ia=MDH. Briefly, RT-PCR was performed on 150 ng of total RNA using the following program: 42 C for 30 min, 99 C for 5 min, and 4 C for 5 min. Equivalent amounts (2.0 mg) of primers for both genes were added to a master mix of PCR reagents (2.5 units AmpliTaq, a final concentration of 2 mM MgCl 2 and 1Â PCR buffer II and water). Aliquots of 45 ml aliquots were placed in six tubes and amplification was performed as follows: 95 C for 2 min; and cycles of 95 C for 1 min, 60 C for 1 min, and 72 C for 2 min. Tubes were removed at 20, 22, 24, 26, 28 and 32 cycles and samples electrophoresed on a 1.2% agarose gel (Mallinckrodt: pulsed field GenAR agarose) containing 50 mg ethidium bromide ( Figure 1) . Densitometry of the photographed gel was performed using the Kodak 1D software (Rochester, NY, USA). The log of band density vs cycle number was plotted to find the linear range for both products and then the ratio of the products was determined in the linear range. The linear range is defined as a point along both gene curves where the curves are both linear and parallel. The linear range for NOS-III and GAPDH was identified between cycles 23 and 26, between cycles 26 and 28 for NOSIb and MDH, and between cycles 26 and 28 for NOSIa and MDH. 16 Assays were performed in triplicate on individual tissue specimens and the product ratios reported as the mean plus or minus the standard error of the mean. When determined in this fashion the ratio of the products was independent of the input RNA concentration and was a reliable indicator of relative abundance of expression. 32 Statistically significant differences in expression were evaluated by a Student's t-test or by twoway ANOVA. Homogenization of penis tissue is difficult due to the collagen-rich nature of the tissue and thus the yield of RNA isolated from a single penis is minimal, making quantification of gene expression difficult using less sensitive techniques such as Northern analysis. Non-competitive RT-PCR as a method of gene quantification has been utilized successfully in the past by members of our laboratory to quantify many different genes during embryogenesis and postnatal morphogenesis. 16, [28] [29] [30] [31] This technique allows us to determine if gene expression is altered but does not yield the exact amount of starting RNA. We feel this technique is useful for our purposes. NOS-II was not quantified because its amplification curves was not linear with GAPDH or MDH. NOS-Ic has not been identified in penis tissue. 16 
Synthesis of NOS-II and NOS-III riboprobes
Primers outlined in Table 1 were used to synthesize riboprobes for NOS-II and NOS-III. 16 Briefly, an RT-PCR product was synthesized, ligated and transformed into the pCRII vector using the protocol outlined in the TA Cloning kit (Invitrogen, Carlsbad, CA, USA). Colonies with insert were selected based on their coloration after exposure to X-Gal (Promega, Madison, WI, USA). Colonies with insert were restreaked onto separate plates. PCR on the colonies was performed using an M-13 primer (CAG GAA ACA GCT ATG AC) and the NOS primers (outlined in In situ hybridization
In situ hybridization was performed on CN resected and control penises that were fixed in 4% paraformaldehyde to determine the localization of NOS-II and NOS-III post CN injury. Paraffin embedded penises were sectioned 8 microns in thickness, rehydrated, fixed in 4% paraformaldehyde, washed in 1Â PBS and digested in proteinase K (20 mg=ml). Sections were fixed in 4% paraformaldehyde, washed in PBS, treated with 0.1 M TEA and acetylated in 0.25% acetic anhydride. After washing, NOS-II and NOS-III probes (probes designed with RT-PCR primer sequences outlined in Table  1 ) 16 were diluted 1=100 in hybridization solution and sections were incubated overnight at 65 C in a humidified chamber. Slides were washed with 0.2Â SSC at 72 C for 1 h, washed with 0.2Â SSC, and blocked with 10% heat-inactivated horse serum (Gibco) in buffer B1 (B1:0.1 M Tris pH 7.6, 0.15 M NaCl). Sections were incubated with 1=1000 diluted anti-DIG antibody in B1 with 1% horse serum (Gibco) overnight at 4 C. Slides were washed with B1, AP buffer (100 mM Tris pH 9.5, 50 nM MgCl, 100 mM NaCl), developed in NBT=BCIP (Boehringer Mannheim, Indianapolis, IN), and mounted with Crystal Mount mounting media (Biomedia, Foster City, CA, USA).
Immunohistochemical analysis
Immunohistochemical analysis was performed using the protocol outlined in the DAKO LSAB peroxidase kit. Briefly, penis tissue was fixed in 4% paraformaldehyde overnight and paraffin sections were cut 8 m thick. Sections were rehydrated, boiled for 40 s in unmasking solution (Vector, Burlingam, CA, USA) and incubated for 4 min. Sections were washed in 1Â PBS and treated with 3% peroxide. Sections were washed in PBS and blocked with swine serum (DAKO, Careinteria, CA, USA) for 1 h. Sections were incubated with either a mouse monoclonal antibody (Transduction Laboratories, Lexington, KY, USA) for NOS-I, NOS-II or NOS-III, for alpha smooth muscle actin (Sigma, St Louis, MO, USA) or for CD31 (DAKO, Careinteria, CA, USA) that had been diluted 1=100 in PBS=swine serum at 4 C overnight. After washing, the standard protocol included in the DAKO LSAB peroxidase kit was followed. Sections were stained with DAB or DAB with nickel and mounted using Crystal Mount mounting media (Biomedia, Foster City, CA, USA).
Quantitation of NOS-I and NOS-III proteins by Western blot analysis
CN injured and control penises were homogenized in PBS with protease inhibitors (PMSF, EDTA, Leupetin), diluted in 2Â sample buffer (10 mM Tris, 4% SDS, 200 mM dithiothreitol, 10% glycerol, 0.2% bromophenol blue) and heated at 95 C for 5 min. Samples were cooled and the protein content measured by the Lowery method. Proteins were separated via electrophoresis using 7.5% polyacrylamide gel (PAG) for 4 h. Proteins were transferred to a 0.45 m nitrocellulose membrane using a Hoefer Semi-phor Semi-Dry Electroblotter, for 3 h. After overnight blocking in 5% powdered milk in PBS with 0.01% sodium azide at 37 C, membranes were incubated in either a mouse monoclonal NOS-I, NOS-III (Transduction Laboratories, Lexington, KY, USA) or b-actin (Sigma, St Louis, MO, USA) antibody for 18 h at 4 C. Following primary antibody incubation, the membranes were washed three times for 15 min each with PBS-T. Membranes were then incubated with Affini Pure goat-anti-mouse IgG conjugated to horseradish peroxidase (Jackson Immuno Labs; 1:20 000 dilution) for 4 h at 37 C. After washing with PBS-T, protein bands were visualized using enhanced chemiluminescence detection reagent (ECL Western Blotting Analysis System, Amersham) according to manufacturers directions and exposed to Kodak (Eastman Kodak) X-AR2 film for 1-5 min. Protein bands were quantified by densitometry using Kodak 1D software (Rochester, NY, USA). Quantitation was performed by comparing the density of NOS-I and NOS-III bands to b-actin (Sigma, mouse monoclonal antibody) in order to eliminate differences in protein loading. Statistics were performed by two-way ANOVA.
Results
Relative abundance of NOS isoforms in the penis
The relative abundance of NOS isoforms (NOS-Ia, -Ib and -III) was measured by quantitative RT-PCR in adult penises (postnatal day 120, P120) in order to gain insight into isoform interaction. MDH was used as an endogenous internal standard. NOS-III was most abundant in normal penises (1.14, Figure 1 ). This seems reasonable since NOS-III was localized in highly abundant tissues of the penis including smooth muscle and endothelium lining the corpora cavernosal spaces. Since NOS-I was primarily localized in nerves of the dorsal nerve bundle and in the pelvic ganglia (remote from the penis), tissues which comprise only a small fraction of the total penile mass, both isoforms of NOS-I were present in significantly less abundance than NOS-III. However, NOS-Ia (0.41) was % 4-fold more abundant than NOS-Ib (0.11) in normal penises. NOS-Ic was not identified in our observations of the penis (data not shown 16 ). NOS-II expression could not be quantified by this method for comparison. The expression of several NOS-I isoforms in the penis is an intriguing finding that requires further study to reveal potential functional impact. 
NOS-III expression was also quantified in control (n ¼ 4) and CN cut (n ¼ 4) penises using GAPDH as an endogenous internal standard ( Figure 2C ). NOS-III expression was unaltered post CN resection at all points assayed (C7 ¼ 0.13, CN7 ¼ 0.14, P-value ¼ 0.31; C14 ¼ 0.11, CN14 ¼ 0.13, P-value ¼ 0.31; C21 ¼ 0.11, CN21 ¼ 0.11, P-value ¼ 0.45). 
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These results show that NOS-Ia and -Ib are present in the penis from sources other than the pelvic ganglia and that these sources are unaffected by loss of innervation. These internal sources of NOS were unable to upregulate to restore erection potential in the absence of a neural stimulatory pathway. Expression of NOS-Ia, -Ib and -III in the penis post CN resection was unaltered due to the induced neuropathy.
Distribution of NOS-II and NOS-III mRNA was unchanged post cavernous nerve injury
Under normal homeostatic conditions mRNA of both NOS-I and -III isoforms is localized in the pelvic ganglia 16 and does not travel down the nerves into the dorsal nerve bundle. NOS protein is not restricted in this manner and can travel down the nerve. Thus NOS-I protein has been detected in abundance in nerves of the dorsal nerve bundle. 16, 33 This observation must be taken into account when describing the localization of NOS isoforms by in situ hybridization. Other pertinent areas of the penis in which NOS isoforms were identified were smooth muscle, the endothelial lining of the corporal cavernosal spaces and the epithelium of the urethra.
The effect of bilateral denervation on NOS-III mRNA distribution was evaluated by in situ hybridization in control (n ¼ 3) and CN cut (n ¼ 3) penises 7, 14 and 21 days post CN resection. NOS-III was expressed in smooth muscle, the endothelial lining of the corpora cavernosa and in the epithelium of the urethra (Figure 3 ). This confirms our previous observations of NOS-III expression in control and diabetic penises. 16 NOS-III was not observed in the nerves of the dorsal nerve bundle as was predicted from our understanding of penile physiology ( Figure  3 ). NOS-III staining was unchanged in the corpora and urethra post CN resection at all time points assayed ( Figure 3) .
In situ hybridization was also performed on control (n ¼ 3) and CN cut (n ¼ 3) penises assaying for NOS-II, 7, 14 and 21 days post CN resection. In control penises, NOS-II was expressed in smooth muscle, the endothelial lining of the corpora cavernosa and in the epithelium of the urethra ( Figure 4 ), confirming our earlier findings in control and diabetic penises. 16 The distribution of NOS-II RNA was unaltered in the corpora and urethra post CN injury. NOS-II expression often accompanies inflammation. An increase in NOS-II localization was not observed after CN injury, indicating that the process by which ED occurs after denervation is not likely to be mediated by inflammation.
Immunohistochemical analysis of the distribution of NOS-I, -II and -III in the penis post CN
The distribution of NOS protein and mRNA were not identical since only the protein travels down the CN to reside in the nerves of the dorsal nerve bundle. After bilateral CN injury stimulation of the penis by the CN was lost and thus it was hypothesized that any NOS protein originating in the pelvic ganglia and CN would be unable to travel down the nerve and thus be absent after CN resection.
Immunohistochemical analysis was performed to determine the distribution of NOS-I protein in control (n ¼ 3) and CN cut (n ¼ 3) penises 7, 14 and 21 days post CN resection. NOS-I protein was localized in control penises primarily in the nerves of the dorsal nerve bundle (Figure 5 ), however, it was also present in the epithelium of the urethra and in the smooth muscle lining of the corpora cavernosa. These results confirm those described previously in our laboratory which describe NOS-I protein distribution in control and diabetic penises. 16 Seven days post CN injury NOS-I protein remained abundant in the nerves of the dorsal nerve bundle and in the urethra but was barely detectable in the corporal tissue. Fourteen days post CN injury NOS-I protein was absent by immunohistochemical analysis in the nerves of the dorsal nerve bundle and in the corpora cavernosa. The loss of NOS-I protein remained evident at 21 days post CN. The distribution of NOS-I protein in the urethra was unchanged post CN injury. These results describe a dramatic decrease in NOS-I protein in the penis after bilateral CN resection and suggest that NOS-I protein was the primary NOS isoform affected post radical prostatectomy where nerve viability was crucial.
The localization of NOS-III protein was examined by immunohistochemical analysis in control (n ¼ 3) and CN (n ¼ 3) injured penises 7, 14 and 21 days post CN resection. NOS-III protein was distributed in smooth muscle, the endothelial lining of the corpora cavernosa and in the epithelium of the urethra of normal penises ( Figure 6 ). NOS-III protein was not observed in or around the nerves of the dorsal nerve bundle. This result confirms our previously described observations of NOS-III localization in control and diabetic penises. 16 NOS-III protein distribution appeared unaltered at all points assayed after CN injury.
The localization of NOS-II protein was evaluated by immunohistochemical analysis in control (n ¼ 3) and CN resected (n ¼ 3) penises 7, 14 and 21 days post CN. NOS-II protein was distributed in the smooth muscle lining the corpora cavernosal spaces and the epithelium of the urethra (Figure 7 ). NOS-II protein was clearly absent in the nerves of the dorsal nerve bundle. The localization of NOS-II protein appeared unaltered post CN resection at all time points assayed (Figure 7 ; data not shown for CN14 and CN21). NOS-II is often expressed in response to immunological stimulation and=or inflammation. [19] [20] [21] [22] The lack of NOS-II up-regulation suggested that the ED that often accompanies radical prostatectomy was not attributable to an inflammatory response of the penis but rather to neuropathy and the direct action of withdrawing innervation.
These results show that NOS-I was the primary NOS isoform affected under conditions that mimic post-radical prostatectomy, CN resection. To our knowledge this is the first report showing differential changes in NOS isoforms after denervation. 
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A differential decrease in protein abundance of NOS isoforms post CN injury: Western analysis
Immunohistochemical analysis is invaluable for determining the localization of a protein within a tissue, however, it is not a quantitative technique and thus observations concerning protein abundance must be made using other established techniques such as Western blot. In order to evaluate potential interaction of NOS isoforms in achieving erection it would be beneficial to understand how NOS isoform abundance changes after denervation under conditions that mimic radical prostatectomy, bilateral CN resection.
NOS-I protein abundance was measured by Western blot analysis in control (n ¼ 4) and CN resected (n ¼ 4) penises 7, 14 and 21 days post CN injury. NOS-I protein was significantly decreased % 17-fold 7 days post CN injury (Figure 8 , Pvalue ¼ 0.002). This decrease remained apparent 14 and 21 days post CN resection (P-value for CN14 ¼ 0.002, P-value for CN21 ¼ 0.0001) so was not a transient observation and can be attributed to denervation. These results show that NOS-I protein was down-regulated post CN injury and confirm our immunohistochemical findings in which NOS-I protein was undetectable primarily in the nerves but also in the corporal tissue 14 and 21 days post CN resection.
NOS-III protein abundance was measured in control (n ¼ 4) and CN resected (n ¼ 4) penises 7, 14 and 21 days post CN injury by Western blot analysis. NOS-III protein abundance was unaltered post CN ( Figure 9 , P-values ! 0.05). This result confirms our immunohistochemical studies that show unaltered NOS-III protein distribution post CN resection. We did not find any evidence to suggest compensation by NOS-III for the loss of NOS-I protein.
These results show that NOS therapy directed towards restoring depleted NOS-I after prostatectomy may be a good avenue for pharmacological intervention in the future.
Immunohistochemical analysis of alpha smooth muscle actin
Changes in smooth muscle and endothelium were evaluated by immunohistochemical analysis using antibodies specific for smooth muscle (alpha smooth muscle actin) and endothelium (CD31). Immunohistochemical analysis was performed on control (n ¼ 3; A, C and E) and CN cut (n ¼ 3; B, D and F) penises assaying for alpha smooth muscle actin 21 days post CN resection (Figure 10 ). This was done in order to visualize changes in the smooth muscle lining the cavernosal spaces. Control penises displayed actin in two distinct areas of the corpora, the smooth muscle lining the corporal spaces and smooth muscle cells interspersed throughout the corpora cavernosa ( Figure 10A ). The individual smooth muscle cells interspersed within the corporal tissue were almost completely absent 21 days post CN ( Figure 10B ). The staining in the lining of the cavernosal spaces had also become altered to have a non-uniform appearance 21 days post CN ( Figure  10D ). It was unclear what this signified, however, the staining differed visually from the control ( Figure 10C ). The endothelium lining the corporal space, adjacent to the smooth muscle ( Figure 10C) , was visible as a clear layer inside the smooth muscle lining. This was confirmed ( Figure 10E ) using immunohistochemical analysis with a CD31 antibody that is an endothelial specific adhesion molecule. 34 By 21 days post CN the endothelial lining was almost completely absent ( Figure 10F ).
Discussion and conclusions
A frequent side effect observed post radical prostatectomy is ED. It has been demonstrated that saving one neurovascular bundle can retain some erectile function. After nerve-sparing radical prostatectomy, the recovery rate of erectile function was 49% 3 y post surgical intervention and as high as 79% after 5 y. 10 The recovery of sexual intercourse rates were much lower, 36 and 57%, respectively. 10 Thus, neural integrity was critically important for maintaining erectile function. Some degree of neural regeneration may occur if one neurovascular bundle remained intact. 8 This has been shown in rodent models after unilateral CN resection 4, 8 and was supported in humans by the higher rate of recovery of erectile function with time. Three months after unilateral CN resection in rats, regeneration was observed on the cut side that presumably originated from nerves of the intact side 7 although sources of neural innervation remain controversial. If both of the CN had been damaged then regeneration could not occur and the loss of erectile function remained permanent. 8 Unilateral denervation by CN resection provides a good model to explore neural regeneration. 7 However, bilateral CN resection more accurately depicts the circumstance of individuals with permanent nerve damage. This includes patients that do not regain erectile function after prostatectomy or cryoblation of the prostate 5 and those in which nerve sparing radical prostatectomy is not an option. Individuals capable of neural regeneration may regain function with time. Neural stimulation of the penis is primarily regulated by NOS. A more precise understanding of how the NOS isoforms Figure 8 Western analysis of NOS-I protein in control and CN cut penises 7, 14 and 21 days post CN injury. NOS-I protein was significantly decreased post CN resection at all time points measured (CN7, P < 0.002; CN14, P < 0.002; CN21 < P < 0.0001). The density of NOS-I protein was measured by comparison to b-actin in order to eliminate variability in protein loading. Insert shows one of the Western blots from which NOS-III was quantified.
NOS isoforms post CN injury CA Podlasek et al interact to achieve erection has great potential to improve treatment options in this patient population in which other treatment options have limited effect. 1 Treatments that are directed towards this putative interaction may harbor great advantages as future therapies.
How NOS isoforms interact to achieve erection is a complex process involving several different isoforms with both overlapping and unique expression domains. Often several forms of a protein exist within a tissue. These isoforms can co-localize or be exclusively expressed in different tissue layers. Localization affords valuable insight into function. When the function of an isoform is lost, perhaps due to genetic manipulation or neuropathy following invasive surgery, another isoform can sometimes compensate for the lost function. 28, 30, 31 There are several NOS isoforms (-I, -II and -III) which have been identified in the penis. These isoforms are further subdivided by varying splice variants (-Ia and -Ib). NOS is essential for normal erectile function, however, the exact role of the isoforms and variants remains unclear. NOS-III is notably the most abundant isoform. It is prevalent in the urethra and in both the smooth muscle and endothelium of the corpora cavernosa, which are plentiful tissues in the penis. While mRNA for NOS-III was noted previously in the pelvic ganglia, 16 this did not translate to NOS-III mRNA or protein observed in nerves of the dorsal nerve bundle. NOS-I was primarily expressed in the nerves of the dorsal nerve bundle, which form a much smaller but highly significant fraction of the penis since denervation completely negates spontaneous erectile potential. It was also detected in the corpora and the urethra. Whether NOS-I protein was localized to nerves underlying the corporal smooth muscle or to the smooth muscle itself was unclear. Since both NOSIa and NOS-Ib were expressed in the penis it is possible that one or the other was exclusive to the nerve and to the smooth muscle of the corpora, however, further study is required to evaluate this potential dichotomy. NOS-I and NOS-III appear to have some overlap in their expression domains in the corpora, however, NOS-I is unique in the nerves of the dorsal nerve bundle. So NOS-I and NOS-III appear to function primarily in the nerves and smooth muscle=endothelium of the corpora, respectively. The role of NOS-II in erection is more obscure and will be evaluated in more detail below. The potential for compensation by alternative isoforms remains controversial when discussing ED. Although both vascular and neural components are essential for erection, ED resulting after radical prostatectomy appears to be primarily a neural phenomenon. This was supported by retention of some erectile function after nerve sparing radical prostatectomy and by our observation of significantly decreased NOS-I protein post bilateral CN resection. For those patients in which erectile function was not retained after surgical intervention, NOS therapy may be feasible and is the subject of current investigation. [35] [36] [37] Evidence for potential compensation of NOS isoforms, while not comprehensive, does exist. In NOS-I deficient mice, levels of NOS-III were elevated and erectile function was maintained. 38 These mice also retained intact CN so an avenue of innervation by the central nervous system remained intact. NOS-I may compensate for NOS-III since NOS-III deficient mice retained erectile function. 39 During regeneration of nerves post unilateral CN resection both NOS-I and -III proteins were upregulated 6 and erectile function recovered. A definite relationship between NOS-I, -III and erectile function is emerging. NOS-III could not compensate for loss of NOS-I without a partially intact neural network. This was consistent with our bilateral CN injury model in which NOS-I protein was dramatically decreased, and in the absence of innervation, erection could not occur despite the presence of NO synthesized by NOS-III. These results suggest that elevated NOS-III might compensate for decreased NOS-I and maintain erectile function and vice versa as long as a stimulatory pathway from the central nervous system remains intact. Therefore NOS therapy may be possible to improve erectile function in individuals which retain at least partial innervation. The presence of NOS-II in the penis under normal conditions is puzzling since it is an inducible form of NOS that is involved in the inflammatory response. The importance of NOS-II to maintenance of erectile function remains unclear. NOS-II was expressed in the urethra. This is perhaps understandable in that the urethra would need to have a vigorous system in place for fighting infection because of the potential for inoculation during intercourse. This was perhaps the reason why NOS-II was expressed in the corpora cavernosa as well. Constant changes in blood flow through the cavernosal spaces could result in sheer stress that challenges tissue integrity. NO produced by NOS-II is known to play a role in inflammation and inflammatory diseases, including: rheumatoid arthritis, 22 inflammatory bowl disease, 19 myocardial and coronary inflammation and dysfunction, 21 circulatory shock, atherosclerosis, cardiac allograft rejection, chronic inflammation, corneal disease 20 and cancer. 40 Cytokines, microbial components, immune complexes and mechanical stress can induce NOS-II mRNA transcription. NO is beneficial for immunology self-defense but is potentially toxic. 40 The localization of NOS-II appeared unaltered after bilateral CN resection. Abundant up-regulation of NOS-II was not evident after bilateral CN resection, as was the case in our previous findings with diabetic neuropathy. 16 This suggests that the changes in erectile function observed post radical prostatectomy could not be attributed to an inflammatory response by the penile tissue and that compensation by NOS-II was not observed.
ED observed post radical prostatectomy was most likely attributable to smooth muscle and endothelial changes observed after nerve injury. Twenty-one days post bilateral CN resection there was a profound decrease in the number of smooth muscle and endothelial cells. The observed decrease appeared predominantly among smooth muscle cells that were interspersed within the collagen matrix. However, the smooth muscle lining the corporal cavernosal spaces also appeared changed after CN resection. Immunohistochemical analysis showed patchy staining with a non-uniform distribution of smooth muscle lining the corporal spaces. These observations were not apparent in normal penises. These results are supported by reports of increased apoptosis and decreased DNA content in the corpora after CN resection. 41 Dramatic endothelial changes were also observed post CN injury. The endothelial lining of the corpora cavernosa was viewed in normal penises as a thin, continuous layer adjacent to the smooth muscle ( Figure 10C and E). Twentyone days post CN resection the endothelial layer was almost completely absent. This result was very similar to endothelial disruption observed in the streptozotocin-model of diabetes 42 which exhibits neuropathy and ED. Further analysis is required to determine if NOS therapy could remodel the corpora to resemble the normal architecture.
Differences in expression of NOS mRNA and protein were apparent in the nerves of the penis. NOS mRNA for isoforms -I and -III was observed previously in the pelvic ganglia, 16 however, the mRNA did not travel down the nerve to be observed in nerves of the dorsal nerve bundle. NOS-I protein was not restricted to the pelvic ganglia and was observed abundantly in nerves of the dorsal nerve bundle. When discussing NOS localization in the penis this physiological difference becomes significant.
The observation that NOS-Ia and -Ib were identifiable in the penis that did not originate from the pelvic ganglia via the CN was an interesting finding. This suggested that the individual splice variants of NOS-I may arise due to differences in their localization. One of the variants may localize in the nerves of the dorsal nerve bundle whereas the other may be present in the corporal smooth muscle and urethra. This is of particular interest since it is neuronal NOS that is crucial to supply innervation required for erection. NOS-I variants are promising as agents for ED treatment in the presence of at least partial neural innervation and a better understanding of their interaction and localization is crucial. NOS-III and -II were unable to compensate for loss of NOS-I in the absence of a neural stimulatory pathway to the central nervous system. These results show the importance of maintaining at least partial innervation of the penis after surgical intervention and that NOS-I was the primary NOS isoform affected under conditions that mimic post-radical prostatectomy, CN resection. To our knowledge this is the first report showing differential changes in NOS isoforms after denervation. These studies show that NOS therapy presents a good avenue for pharmacological intervention directed towards restoring depleted NOS-I after prostatectomy.
